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Abstract
Introduction:  The  complex  relationship  between  sleep  disorders  and  hormones  could  lead  to
alterations  in  the  production  of  cortisol  and  testosterone  in  obstructive  sleep  apnea  (OSA)
patients.
Objective:  The  purpose  of  this  study  was  to  determine  the  diurnal  trajectories  of  salivary  free-
testosterone,  free-cortisol  and  their  ratio  (T/C).
Methods:  Ten  subjects  newly  diagnosed  with  OSA,  based  on  nocturnal  polysomnography  eval-
uation and  excessive  daytime  sleepiness,  and  seven  matched  controls  were  consecutively
recruited. Cortisol  and  testosterone  were  measured  in  salivary  samples  collected  upon  awaken-
ing, at  noon  and  in  the  evening.  The  psychometric  evaluation  of  anxiety/depression  and  referred
sexual function  disturbances  was  performed  to  evaluate  the  presence  of  neuropsychological
comorbidities.
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Results  and  conclusion:  The  main  ﬁnding  was  that  OSA  subjects  displayed  hypocortisolism  upon
awakening  and  a  signiﬁcant  reduction  in  testosterone  concentration  in  the  evening  in  compar-
ison with  the  control  group,  which  has  maintained  the  physiological  testosterone  and  cortisol
diurnal ﬂuctuation,  with  higher  hormone  concentrations  in  the  morning  and  lower  concentra-
tions in  the  evening.  The  use  of  data  from  multiple  diurnal  measurements  rather  than  a  single
point allowed  the  detection  of  T/C  ratio  changes  of  opposite  signs  at  the  beginning  and  end  of
the day:  the  OSA  subjects  had  a  higher  T/C  ratio  than  the  controls  in  the  morning,  while  their
T/C ratio  was  signiﬁcantly  lower  than  that  of  the  controls  in  the  evening.  The  imbalances  in
the anabolic-catabolic  diurnal  equilibrium  suggest  that  OSA  is  associated  with  a  dysregulation
of the  hypothalamic--pituitary--adrenal  and  hypothalamic--pituitary--gonadal  axes,  potentially
an underlying  cause  of  some  of  the  neuropsychological  comorbidities  observed  in  OSA  patients.
© 2015  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published
by Elsevier  Editora  Ltda.  This  is  an  open  access  article  under  the  CC  BY  license  (http://
creativecommons.org/licenses/by/4.0/).
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Desequilíbrio  na  proporc¸ão  salivar  diurna  de  testosterona/cortisol  em  homens
com  apneia  obstrutiva  do  sono  grave:  um  estudo  observacional
Resumo
Introduc¸ão:  A  relac¸ão  complexa  entre  os  distúrbios  do  sono  e  os  hormônios  pode  levar  a
alterac¸ões na  produc¸ão  de  cortisol  e  testosterona  em  pacientes  com  Apneia  obstrutiva  do  sono
(AOS).
Objetivo: O  objetivo  deste  estudo  foi  determinar  as  curvas  diurnas  de  testosterona  e  cortisol
livres na  saliva  e  sua  proporc¸ão  (razão  T/C).
Método:  Dez  indivíduos  recém-diagnosticados  com  AOS  com  base  na  avaliac¸ão  por  polissono-
graﬁa noturna  e  sonolência  diurna  excessiva  e  sete  controles  pareados  foram  recrutados,
consecutivamente.  Cortisol  e  testosterona  foram  medidos  em  amostras  de  saliva  coletadas  ao
acordar, ao  meio-dia  e  à  noite.  A  avaliac¸ão  psicométrica  dos  distúrbios  de  ansiedade/depressão
e func¸ão  sexual  mencionados  foi  realizada  para  detectar  a  presenc¸a  de  comorbidades  neurop-
sicológicas.
Resultados:  O  achado  principal  foi  que  os  indivíduos  com  AOS  apresentam  hipocortisolismo  ao
acordar e  uma  reduc¸ão  signiﬁcante  na  concentrac¸ão  de  testosterona  à  noite,  em  comparac¸ão
com o  grupo  controle,  que  manteve  a  variac¸ão  ﬁsiológica  diurna  de  testosterona  e  cortisol
com concentrac¸ões  hormonais  mais  elevadas  pela  manhã  e  concentrac¸ões  mais  baixas  durante
a noite.  O  uso  de  dados  de  várias  mensurac¸ões  diurnas,  em  vez  de  uma  única  mensurac¸ão,
permitiu detectar  as  alterac¸ões  na  razão  T/C  de  sinais  opostos  no  início  e  no  ﬁnal  do  dia:
os indivíduos  com  AOS  apresentaram  razão  T/C  maior  que  os  controles  na  parte  da  manhã,
enquanto que  a  razão  T/C  foi  signiﬁcantemente  inferior  à  dos  controles  durante  a  noite.
Conclusão:  Os  desequilíbrios  no  balanc¸o  anabólico-catabólico  diurno  sugerem  que  a  AOS  está
associada a  uma  desregulac¸ão  dos  eixos  hipotálamo-hipóﬁse-adrenal  e  hipotálamo-hipóﬁse-
gonadal, potencialmente  a  causa  subjacente  de  algumas  das  comorbidades  neuropsicológicas
observadas  em  pacientes  com  AOS.
© 2015  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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bstructive  sleep  apnea  (OSA)  is  a  chronic  respiratory
isturbance  that  can  be  diagnosed  with  an  overnight
olysomnography  (PSG).  It  is  a  serious  health  problem  with
revalence  greater  than  26%  in  the  general  middle-aged
opulation.1--3
Excessive  daytime  sleepiness  and  snoring  are  often
ssociated  with  neuropsychological  symptoms,  includ-
ng  concentration  difﬁculties  and  cognitive  disturbances.
ypoxia,  sleep  fragmentation,  obesity,  and  ageing  in  OSA
i
oatients  were  found  to  be  associated  with  low  serum  testos-
erone  levels.  Luboshitzky  et  al.4 demonstrated  that  men
ith  sleep  apnea  had  decreased  levels  of  testosterone  and
uteinizing  hormone  during  nightly  sleep,  which  is  possibly
aused  by  the  combined  effects  of  hypoxia  and  sleep  frag-
entation.  More  recently,  Bercea  and  co-workers  reported
hat  the  morning  serum  testosterone  concentration  in  obese
atients  with  severe  OSA  was  associated  with  increased  anx-
ety/depression  and  sleep  efﬁciency  disturbances.5
The  complex  relationship  between  nocturnal  sleep  dis-
rders  and  the  hypothalamic--pituitary--adrenal  (HPA)  axis
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aTestosterone/cortisol  ratio  in  obstructive  sleep  apnea  
could  lead  to  alterations  in  the  production  of  cortisol.6--9
Testosterone  and  cortisol,  major  end  products  of  the
hypothalamic--pituitary--gonadal  (HPG)  axis  and  the  HPA
axis,  respectively,  are  part  of  a  biological  balance  that
modulates  psychologically  and  physically  integrated  human
responses.  The  interrelationship  between  sex  and  stress  hor-
mones  has  been  extensively  investigated  in  the  context
of  sports  medicine  by  measuring  the  testosterone/cortisol
(T/C)  ratio  as  a  marker  of  anabolic/catabolic  activities
connected  with  athlete  performance  and  overtraining.10--11
Furthermore,  the  T/C  ratio  has  been  proposed  as  a  hormonal
marker  of  psychopathologies,12,13 and  a  speciﬁc  association
between  a  reduction  of  the  T/C  ratio  and  ischemic  disease
has  also  been  reported.14
The  purpose  of  this  study  was  to  determine  the  diurnal
ﬂuctuation  of  salivary  free-testosterone  (T)  and  free-
cortisol  (C)  and  to  study  their  interrelationship  by  measuring
diurnal  variations  in  the  T/C  ratio  of  patients  with  severe
OSA.  This  analysis  will  expand  upon  previous  studies  that
provided  only  partial  data  from  single-point  hormonal  mea-
surements.
Interestingly,  sex  hormone  imbalance  is  often  associated
with  depressive  and  anxious  mood  disorders  in  men15 and
bidirectionally  interacts  with  erectile  function.16 Therefore,
to  assess  the  presence  of  comorbidities,  the  Hamilton  Inven-
tory  Questionnaires  for  Depression  (HDS)  and  Anxiety  (HAS)
and  the  International  Index  for  Erectile  Function  (IIEF)  ques-
tionnaire  were  administered  to  the  study  population.
Materials and methods
Study  population
This  prospective  study  was  conducted  over  6  months
between  May  2011  and  December  2012  in  the  Sleep  Labo-
ratory  in  the  Clinic  of  Pulmonary  Diseases  (Iasi,  Romania).
The  study  was  formally  approved  by  the  local  Ethics  Commit-
tee  (Protocol  n◦ 14,  April  29th,  2011).  All  Caucasian  subjects
were  recruited  among  patients  visiting  the  Centre  for  Sleep
Disturbances  and  provided  their  written  informed  consent
before  the  start  of  the  study.
We  previously  estimated  that  at  least  14  subjects  (7
per  group)  were  required  to  detect  a  mean  absolute  dif-
ference  corresponding  to  a  50%  variation  on  the  expected
peak  of  T/C  ratio  in  healthy  subjects  (40.00  ±  20.00  arbi-
trary  unit)  with  a  two-tailed  ˛  of  0.05  and  80%  of  power
analyses.  Thus,  10  patients  (OSA  group)  were  selected  based
on  the  following  inclusion  criteria:  male,  40--60  years  old,
non-smoker,  with  body  mass  index  (BMI)  >30  kg/m2 (obese)
and  newly  diagnosed  with  severe  OSA  based  on  noctur-
nal  polysomnography  (PSG)  evaluation  (apnea-hypoapnea
index,  AHI  ≥  30  h−1)  and  excessive  daytime  sleepiness
(Epworth  Sleepiness  Scale,  ESS  ≥  10).17 The  exclusion  crite-
ria  included  the  following:  acute  or  chronic  associated
diseases,  smoking,  use  of  any  chronic  medication  and  non-
cooperative  attitude.  Patients  with  suspected  OSA  were
hospitalized  for  4  consecutive  days.  On  the  morning  of
admittance,  blood  samples  were  collected  for  biochemical-
hematological  parameter  determinations,  and  pulmonary
function  assessment  (spirometry)  and  psychometric  evalu-
ations  with  the  Hamilton  Rating  Scale  for  Depression,18 with
b
f
r531
he  Hamilton  Anxiety  Rating  Scale  and  with  the  International
ndex  Erectile  Function  questionnaire  (IIEF)19 were  per-
ormed.  A  baseline  resting  electrocardiogram  (ECG),  heart
ate  (HR)  (BTL-08  USA)  and  systolic  and  diastolic  blood  pres-
ure  were  recorded  (M3 --  Omron,  Japan).  Conventional
leep  recordings  (SOMNOlab  V2.01,  Weinmann,  Germany)
ere  obtained  from  10:00  pm  to  7:00  am  (day  2)  and
HI,  arterial  oxygen  saturation  (SpO2),  desaturation  index
ODI)  and  microarousal  index,  were  scored  applying  standard
riteria.20 According  to  American  Academy  of  Sleep  Medicine
007,  the  AHI  was  calculated  as  the  mean  number  of  apneas
lus  hypopneas  per  hour  of  sleep;  apneas  were  scored  when
he  absence  of  airﬂow  was  lasting  at  least  10  s  and  hypop-
eas  when  there  was  at  least  a  30%  drop  in  the  oronasal
irﬂow,  with  coincident  oxygen  desaturation  of  at  least  4%,
asting  at  least  10  s.7,20
The  participants  were  instructed  on  how  to  collect  saliva
nd  asked  to  avoid  food,  coffee  and  alcohol  consumption,
eeth  brushing  and  any  physical  exercise  for  at  least  30  min
efore  each  saliva  collection.21 Thus,  on  the  day  after  (day
),  saliva  was  collected  upon  awakening  (between  6:30  h  and
:30  h),  at  noon  (before  lunch)  and  in  the  evening  at  19:00  h
efore  dinner,  for  measuring  the  daily  cortisol  and  testos-
erone  ﬂuctuation.  The  exact  time  of  saliva  sampling  was
onitored  by  a  staff  member.  Among  the  patients  hospital-
zed  with  suspected  OSA,  we  selected  7  adult  male  subjects
or  the  control  group  who  had  the  same  somatic  characteris-
ics  of  the  OSA  subjects  but  did  not  suffer  from  sleep  apnea
AHI  <  5  h−1,  ESS  <  10).
alivary  sampling  procedure,  testosterone  and
ortisol assay
aliva  was  collected  using  the  Salivette  (Sarstedt,  Italy)
ampling  device,  which  allows  for  quick  and  hygienic  saliva
ecovery  through  centrifugation  at  3000  rpm  for  15  min.22
For  each  sample,  duplicate  measurements  were  per-
ormed  for  the  direct  assay  of  testosterone  on  100  L  of
aliva  (inter-assay  coefﬁcient  of  variation  was  <10%,  and
ntra-assay  coefﬁcient  of  variation  <7%  with  a  minimum
etectable  concentration  of  3.5  pg/mL  at  the  95%  conﬁ-
ence  limit  using  commercial  immunoenzymatic  kits  and  for
he  direct  assay  of  cortisol  on  25  L  of  saliva  (inter-assay
oefﬁcient  of  variation  was  <10%,  and  intra-assay  coefﬁcient
f  variation  <7%  with  a  minimum  detectable  concentration
f  0.5  ng/mL  at  the  95%  conﬁdence  limit  (Diametra,  Italy).
ata  analysis
ll  data  were  reported  as  the  mean  ±  SEM.  The  statistical
nalyses  were  performed  and  the  graphics  were  produced
sing  the  SigmaPlot  11  software  package  (SxST.it,  Italy).
ormal  distribution  of  the  data  was  tested  using  the
olmogorov--Smirnov  test.  Where  appropriate,  Student’s  t-
est  or  the  Mann--Whitney  U  test  was  used  as  parametric
nd  non-parametric  tests,  respectively,  for  the  comparisons
etween  groups.
A  two-way  ANOVA  followed  by  the  Fisher  LSD  method
or  post-hoc  multiple-comparison  tests  were  performed  to
eveal  ‘‘GROUP’’,  ‘‘TIME’’,  and  ‘‘GROUP  ×  TIME’’  effects  on
532  Ghiciuc  CM  et  al.
Table  1  Somatic,  polysomnographic,  and  psychometric  variables  in  the  study  population.
Control  (n  =  7)  OSA  (n  =  10)  Statistics  p-Value
Age  (years) 51  ±  3 53  ±  3  T  =  58.000  0.66
BMI (kg/m2)  32.2  ±  0.6  32.3  ±  0.7  T  =  69.000  0.591
Waist circumference  (cm)  105  ±  2  109  ±  2  t  =  −1.623  0.125
Polysomnography  parameters
AHI  (h−1)  2.57  ±  0.48  63.5  ±  9.3  T  =  28.000  <0.001
Minimum SpO2 (%)  87.6  ±  1.49  68.5  ±  4.27  T  =  95.000  0.002
ODI (h-1)  4.86  ±  0.83  58.4  ±  9.35  T  =  28.000  <0.001
Sleep duration  (min)  419.3  ±  8.5  395.3  ±  7.5  t  =  2.088  0.054
Sleep efﬁciency  (%) 79.9  ±  0.7  78.6  ±  0.7  t  =  1.370  0.191
Microarousal  (h-1) 9.9  ±  0.94 46.7  ±  6.31 T  =  28.000 <0.001
ESS 4.0  ±  0.83 12.9  ±  1.23 t  =  −4.910 <0.001
Systemic blood  pressure  and  HR
SBP (mmHg)  117  ±  3  127  ±  2  t  =  −2.744  <0.05
DBP (mmHg)  69  ±  4  76  ±  2  t  =  −1.657  0.118
Heart rate  (beats/min)  67  ±  1  75  ±  2  T  =  48.000  0.156
Psychometric  scores
HDS  5  ±  1  10  ±  0.54  t  =  −5.073  <0.001
HAS 2  ±  1 5.3  ±  1  T  =  38.000  <0.05
EF 27.9  ±  0.7  16.0  ±  0.9  T  =  98.000  <0.001
OF 9.0  ±  0.2 6.9  ±  0.3  T  =  97.000  <0.001
SD 9.1  ±  0.1 6.9  ±  0.2 T  =  98.000  <0.001
IS 14.0  ±  0.2 6.5  ±  0.2 t  =  18.190 <0.001
OS 10.0  ±  0 8.5  ±  0.2 T  =  98.000  <0.001
Data are expressed as the mean ± SEM. BMI, body mass index; AHI, apnea-hypopnea index; minimum SpO2, minimum oxygen saturation;
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aODI, oxygen desaturation index; ESS, Epworth Sleepiness Scale; SB
Depression Score; HAS, Hamilton Anxiety Score; EF, erectile functio
OS, overall satisfaction.
,  C,  and  the  T/C  ratio  measured  in  both  groups  at  7:00,
2:00,  and  19:00  on  the  sampling  day.
The  area  under  the  curve  (AUC)  was  calculated  from  the
UC  determined  for  each  subject  by  the  trapezoidal  method
sing  the  three  salivary  testosterone  values  measured  during
he  sampling  day  (morning,  noon,  and  evening).23
Statistical  signiﬁcance  was  set  at  p  <  0.05.
esults
haracteristics  of  the  study  population
s  reported  in  Table  1,  the  two  groups  were  matched  for
ge,  and  there  were  no  signiﬁcant  differences  in  the  BMI
alues;  the  mean  waist  size  was  similar  for  both  groups  and
as  however  above  the  normal  range  for  men.
The  results  of  the  pulmonary  function  tests  (spirometry),
orced  expiratory  volume  (FEV),  and  vital  capacity  (FEV/VC
atio)  were  within  the  normal  limits  for  subjects  in  both
roups  (data  not  reported).  As  shown  in  Table  1, all  PSG
arameters  were  within  normal  ranges  in  the  control  group.
n  contrast,  the  OSA  group  had  signiﬁcantly  higher  AHI  values
nd  a  signiﬁcant  decrease  in  the  minimum  SpO2,  which  is  a
haracteristic  of  severe  OSA.  The  ODI  was  also  signiﬁcantly
ncreased  in  the  OSA  group.  The  shorter  duration  of  sleep  in
SA  subjects  does  not  reach  statistical  signiﬁcance  and  no
hanges  have  been  detected  in  the  sleep  efﬁcency.  More-
ver,  the  number  of  microarousal  events  was  signiﬁcantly
F
s
stolic blood pressure; DBP, diastolic blood pressure; HDS, Hamilton
, orgasmic function; SD, sexual desire; IS, intercourse satisfaction;
igher  in  the  OSA  group  than  in  the  control  group.  In  addi-
ion,  excessive  daytime  sleepiness,  as  evaluated  by  the  ESS,
as  signiﬁcantly  higher  in  the  OSA  group  than  in  the  control
roup.
Table  1  also  shows  that  the  mean  systolic  blood  pressure
as  slightly  elevated  in  the  OSA  group  compared  to  the  con-
rol  group,  with  no  change  in  diastolic  blood  pressure.  In
ddition,  the  OSA  patients  showed  a  tendency  toward  an
ncreased  HR.
The  Hamilton  Inventory  Scores  for  Depression  (HDS)  and
nxiety  (HAS)  and  the  IIEF  results  for  the  study  population
re  also  reported  in  Table  1.  OSA  patients  had  signiﬁcantly
igher  psychometric  scores  for  anxiety  and  depression  than
he  controls.  The  psychometric  scores  of  the  control  group
ndicated  no  signs  of  depression  or  anxiety.  Furthermore,  the
SA  patients  were  signiﬁcantly  more  likely  to  have  erectile
unction  disorders  than  the  controls.
Individual  hematological  and  serum  biochemical  markers
f  glycemia  and  lipids  (total  cholesterol  and  triglycerides)
ere  within  the  normal  ranges  for  both  groups  (data  not
hown).
iurnal  trajectories  of  salivary  free-testosterone
nd salivary  free-cortisol  in  the  study  populationig.  1  shows  the  salivary  free-testosterone  (upper  panel)  and
alivary  free-cortisol  (lower  panel)  daily  trajectories  for  the
tudy  population.
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Figure  1  Diurnal  trajectories  of  salivary  free-testosterone
and salivary  free-cortisol  in  the  study  population.  The  data
are presented  as  the  mean  ±  SEM.  Statistical  analysis:  a  two-
way ANOVA  followed  by  post-hoc  test  for  multiple  comparisons:
* and  **:  p  <  0.05  and  p  <  0.01,  respectively,  vs.  the  value  at
07:00; †, ††,  and †††:  p  <  0.05,  p  <  0.01,  and  p  <  0.001,  respec-
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Figure  2  Diurnal  trajectories  of  the  T/C  ratio  in  the  study
population.  The  data  are  presented  as  the  mean  ±  SEM.  Statis-
tical analysis:  a  two-way  ANOVA  followed  by  post-hoc  test  for
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analyzed  the  interaction  of  these  two  hormones  by  assessingtively, vs.  the  value  at  12:00; and :  p  <  0.05  and  p  <  0.01,
respectively,  vs.  the  control.
A  two-way  ANOVA  analysis  showed  that  there  were  signif-
icant  differences  in  the  salivary  testosterone  concentrations
measured  at  different  times  of  the  day  (GROUP:  F1,50 =  0.184,
p  =  0.670;  TIME:  F2,50 =  15.350,  p  <  0.001;  GROUP  ×  TIME
interaction:  F2,50 =  3.701,  p  =  0.032).  The  post-hoc  test  for
multiple  comparisons  showed  that  the  Testosterone  concen-
tration  measured  in  the  evening  for  the  control  group
(91  ±  4  pg/mL)  was  signiﬁcantly  lower  than  the  value  in  the
morning  (124  ±  10  pg/mL,  p  <  0.05).  The  same  diurnal  ﬂuc-
tuation  was  detected  in  the  OSA  group;  the  Testosterone
in  the  evening  (54  ±  5  pg/mL)  was  signiﬁcantly  lower  than
that  in  the  morning  (136  ±  14  pg/mL,  p  <  0.001).  In  addi-
tion,  the  Testosterone  concentration  in  the  OSA  group  at
19:00  was  signiﬁcantly  lower  (p  <  0.01)  than  the  Testosterone
concentration  in  the  control  group.  Finally,  no  signiﬁ-
cant  difference  was  detected  between  the  control  group
and  the  OSA  group  in  the  AUC  computed  from  the  diur-
nal  total  Testosterone  production  (1240  ±  53  pg/mL/h  and
1222  ±  108  pg/mL/h,  respectively).
The  C  concentrations  in  the  control  and  OSA  groups  are
reported  in  Fig.  1.  A  two-way  ANOVA  demonstrated  signif-
icant  differences  between  and  within  the  subject  groups
(GROUP:  F1,50 =  9.594,  p  =  0.003;  TIME:  F2,50 =  33.152,
p  <  0.001;  GROUP  ×  TIME  interaction:  F2,50 =  3.753,
p  =  0.031).
t
O
tultiple  comparisons,  *  p  <  0.001  vs.  the  value  at  7  am; † p  <  0.05
s. the  value  at  12  pm; § p  <  0.05  vs.  the  corresponding  control.
In  both  the  control  and  OSA  groups,  the  salivary
ortisol  concentration  in  the  morning  (7.2  ±  0.6  ng/mL
nd  4.6  ±  1.0  ng/mL,  respectively)  was  signiﬁcantly  higher
han  that  in  the  evening  (2.5  ±  0.4  ng/mL,  p  <  0.001  and
.1  ±  0.1  ng/mL,  p  <  0.001,  respectively).  Furthermore,  in
he  morning,  the  Cortisol  concentration  in  the  OSA  group  was
igniﬁcantly  lower  than  that  in  the  control  group  (p  <  0.05).
iurnal  trajectories  of  salivary  T/C  ratio  in  the
tudy population
ig.  2  depicts  the  diurnal  trajectories  of  the  T/C  ratio
n  the  study  population.  A  two-way  ANOVA  demonstrated
igniﬁcant  differences  in  the  T/C  ratio  measured  dur-
ng  the  sampling  day  (GROUP:  F1,50 =  0.633,  p  =  0.431;
IME:  F2,50 =  3.880,  p  =  0.028;  GROUP  ×  TIME  interaction:
2,50 =  5.347,  p  =  0.008).  In  the  control  group,  there  was  a
rogressive  and  statistically  signiﬁcant  increase  in  the  T/C
atio  during  the  sampling  day  (7:00  =  18  ±  9;  12:00  =  27  ±  3;
9:00  =  43  ±  5).  In  contrast,  there  were  no  signiﬁcant  diurnal
uctuations  in  the  T/C  ratio  in  the  OSA  group  (7:00  =  28  ±  3;
2:00  =  34  ±  4;  19:00  =  27  ±  4).  Additionally,  the  T/C  ratio  in
he  OSA  group  was  signiﬁcantly  higher  than  that  in  the  con-
rol  group  in  the  morning  (p  <  0.05)  and  signiﬁcantly  lower
han  that  in  the  control  group  in  the  evening  (p  <  0.05).
iscussion
n  this  study,  we  measured  the  diurnal  trajectories  of  the
alivary  free-testosterone  and  Cortisol  concentrations  andhe  diurnal  variation  of  the  T/C  ratio  in  patients  with  severe
SA.  In  addition,  we  performed  a  psychometric  evalua-
ion  of  anxiety/depression  and  self-reported  sexual  function
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isturbances.  The  major  ﬁnding  of  this  study  is  that  male
bese  OSA  patients  have  a  reduced  T  concentration  in  the
vening  and  a  reduced  C  concentration  in  the  morning  com-
ared  with  non-apneic  obese  controls.  Furthermore,  male
bese  OSA  patients  have  an  imbalance  in  the  T/C  ratio  mea-
ured  in  the  morning  and  in  the  evening.
Sex  hormones  are  believed  to  be  involved  in  the  patho-
enesis  of  OSA  in  adult  male  subjects  who  present  with
educed  levels  of  circulating  androgens.5,16 In  the  present
tudy,  there  were  no  differences  between  the  control  and
SA  groups  in  the  ﬂuctuation  of  the  diurnal  T  trajectory;  the
vening  T  concentration  was  typically  lower  than  the  morn-
ng  concentrations  in  both  experimental  groups.24,25 Salivary
estosterone  concentration  lower  than  controls  also  trans-
ates  in  an  increase  in  comorbidities  (fatigue,  depression,
eneral  reduction  of  the  well-being  sense,  sleep  distur-
ances,  etc.)16 affecting  our  OSA  subjects.  Since  BMI  above
he  normal  range  was  present  in  both  experimental  groups,
SA  itself,  rather  than  obesity,  seems  to  be  the  cause
f  the  drop  of  salivary  testosterone  concentration  in  the
resent  study.  It  has  been  suggested  that  the  morning  rise
n  testosterone  production  is  derived  from  an  endogenous
estosterone  circadian  rhythm  and  is  not  directly  related
o  any  of  the  sleep  stages.26 However,  the  OSA  patients  in
his  study  experienced  a  decrease  in  the  lead  to  stressful
odiﬁcations  of  the  sleep  patterns  with  a  decreased  sleep
fﬁciency.26
In  this  study,  we  demonstrated  that  OSA  subjects  main-
ain  physiological  circadian  activity  in  the  HPA  axis,  with  the
ighest  cortisol  concentrations  present  in  the  morning  and
he  lowest  present  in  the  evening.  The  maintenance  of  reg-
lar  circadian  cortisol  production  in  OSA  subjects  has  also
een  reported  in  a  previous  study27;  however,  these  authors
id  not  detect  any  difference  between  the  OSA  patients  and
ontrols  in  the  morning  cortisol  concentration.  This  discord-
nce  may  be  related  to  the  fact  that  in  the  present  study
s  detected  in  the  saliva  only  the  ‘‘bioactive’’  free  frac-
ion,  which  corresponds  to  the  unbound  free  plasma  fraction
f  the  hormone.7 Indeed,  morning  hypocortisolism  in  OSA
atients  has  been  recently  conﬁrmed.8 The  highest  T  and
 concentrations  occur  at  the  beginning  of  the  day,  while
he  lowest  levels  occur  in  the  evening.25,28 In  our  study,  we
sed  a  three-point  diurnal  sampling  schedule  for  the  ﬁrst
ime  and  were  able  to  detect  a  gradual  increase  in  the  T/C
atio  throughout  the  day.  A  change  in  the  balance  between
he  two  steroid  hormones  may  put  an  individual  at  risk  for
 breakdown  in  homeostasis.  In  the  present  study,  the  OSA
ubjects  had  a  higher  morning  T/C  ratio  than  the  controls;
owever,  in  the  evening,  the  T/C  ratio  was  signiﬁcantly
ower  in  the  OSA  subjects  compared  with  the  control  group.
his  imbalance  in  the  anabolic-catabolic  equilibrium  could
e  attributed  to  the  morning  hypocortisolism  that  charac-
erizes  severe  OSA7,8;  the  resultant  ﬂattened  response  to
hronically  repeated  nocturnal  challenges  reﬂects  a  dysreg-
lation  of  the  HPA  axis.29 In  contrast,  the  decrease  in  the  T/C
atio  in  the  OSA  group  in  the  evening  could  be  a  result  of  the
harp  and  marked  drop  in  the  T  concentration  at  19:00.
Obesity  in  men  is  associated  with  reduced  androgen
ecretion.30 However,  in  the  present  study,  obesity  was  not
onsidered  a  confounding  factor  in  the  T  concentration
eduction  because  obesity  occurred  in  both  groups.  Treat-
ent  of  moderate  to  severe  OSA  with  continuous  positive
t
d
t
sGhiciuc  CM  et  al.
irway  pressure  (CPAP)  does  not  reliably  increase  testos-
erone  levels  in  most  studies.  In  contrast,  a  reduction  in
eight  does  so  predictably  and  linearly  in  proportion  to  the
mount  of  weight  lost.16
Compared  with  the  control  group,  the  OSA  patients
emonstrated  either  a mild  anxious-depressive  disorder
r  excessive  daytime  sleepiness.  Recently,  a  relationship
etween  a  depressive  mood  and  obesity  was  described.31
owever,  the  contribution  of  the  T/C  ratio  imbalance  to  the
evelopment  of  anxious-depressive  symptoms  in  patients
ith  severe  OSA  and  the  key  role  that  obesity  plays  in  the
athogenesis  of  OSA  comorbidities  needs  to  be  further  stud-
ed.
OSA  is  a  recognized  cause  of  sexual  disturbances  in
en.16,32,33 In  this  study,  we  conﬁrmed  that  OSA  patients
uffer  from  mild  to  moderate  sexual  dysfunction  as  assessed
y  the  IIEF  questionnaire.19
onclusions
he  main  ﬁnding  of  this  study  is  that  male  obese  OSA  patients
ave  signiﬁcant  changes  in  the  T  and  C  diurnal  trajectories  in
omparison  with  non-apneic  obese  controls.  Hypocortisolism
as  particularly  pronounced  in  the  morning.  Conversely,
he  T  concentration  was  lowest  in  the  evening.  Moreover,
lthough  OSA  patients  maintained  the  physiological  diurnal
/C  ratio  ﬂuctuation,  they  exhibited  an  imbalance  in  the
iurnal  T/C  ratio  trajectory.
This  study  improved  on  other  previous  studies  by  using
alivary  hormone  measurements  to  detect  the  free  fraction
f  steroid  hormones  in  the  plasma34 and  by  employing  a  tar-
eted  protocol.  In  particular,  the  use  of  data  from  multiple
iurnal  measurements  rather  than  a  single  point  permit-
ed  the  detection  of  T/C  ratio  changes  of  opposite  signs
t  the  beginning  and  end  of  the  day,  allowing  for  a  more
ccurate  study  of  the  HPG  and  HPA  axes.  Finally,  it  is  likely
hat  in  OSA  subjects,  poor  sleep  quality,  tiredness,  and  psy-
hological  distress  are  among  the  comorbidities  affecting
he  responses  crucial  to  the  maintenance  of  the  physiolog-
cal  anabolic-catabolic  hormonal  balance.  However,  we  did
ot  establish  a  causal  relationship  between  these  factors.
n  fact,  a  limitation  of  this  study  is  that  we  only  demon-
trated  the  co-existence  of  imbalanced  T  and  C  production
nd  OSA  comorbidities.  To  fully  address  this  possible  rela-
ionship,  further  research,  with  sample  sizes  adequate  for  a
orrelative  study  design,  is  necessary.
onﬂicts of  interest
he  authors  declare  no  conﬂicts  of  interest.
cknowledgements
he  authors  would  like  to  thank  MASOPHRD  (The  Man-
ging  Authority  for  Sectoral  Operational  Program  Human
esources  Development)  for  providing  ﬁnancial  support  to
MB  as  part  of  the  POSDRU/107/1.5/S/78702  project,  enti-
led  ‘‘Inter-university  partnership  for  increasing  the  medical
octoral  research  quality  and  interdisciplinary  through  doc-
oral  Scolarships-DocMed.net’’.  This  study  was  partially
upported  by  a  grant  from  MIUR  to  FRP,  as  part  of  the
11
2
2
2
2
2
2
2
2
2
2
3
3
3
3Testosterone/cortisol  ratio  in  obstructive  sleep  apnea  
Scientiﬁc  Bilateral  Agreement  between  Sapienza  and  Grig-
ore  T.  Popa  Universities.
References
1. Hiestand DM, Britz P, Goldman M, Phillips B. Prevalence of symp-
toms and risk of sleep apnea in the US population: results from
the national sleep foundation sleep in America 2005 poll. Chest.
2006;130:780--6.
2. Jennum P, Riha RL. Epidemiology of sleep apnoea/hypopnoea
syndrome and sleep-disordered breathing. Eur Respir J.
2009;33:907--14.
3. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive
sleep apnea: a population health perspective. Am J Respir Crit
Care Med. 2002;165:217--39.
4. Luboshitzky R, Lavie L, Shen-Orr Z, Herrer P. Altered luteinizing
hormone and testosterone secretion in middle-aged obese men
with obstructive sleep apnea. Obes Res. 2005;13:780--6.
5. Bercea RM, Patacchioli FR, Ghiciuc CM, Cojocaru E, Mihaescu
T. Serum testosterone and depressive symptoms in severe OSA
patients. Andrologia. 2013;45:345--50.
6. Tomfohr LM, Edwards KM, Dimsdale JE. Is obstructive sleep
apnea associated with cortisol levels? A systematic review of
the research evidence. Sleep Med Rev. 2012;16:243--9.
7. Ghiciuc CM, Dima-Cozma LC, Bercea RM, Lupusoru CE, Mihaescu
T, Szalontay A, et al. Restoring of salivary cortisol awakening
response (CAR) by nasal continuous positive airway pressure
(CPAP) therapy in obstructive sleep apnea. Chronobiol Int.
2013;30:1024--31.
8. Karaca Z, Ismailogullari S, Korkmaz S, Cakir I, Aksu M, Bay-
demir R, et al. Obstructive sleep apnoea syndrome is associated
with relative hypocortisolemia and decreased hypothalamo-
pituitary-adrenal axis response to 1 and 250 g ACTH and
glucagon stimulation tests. Sleep Med. 2013;14:160--4.
9. Patacchioli FR, Tabarrini A, Ghiciuc CM, Dima-Cozma LC,
Prete A, Bianchini C, et al. Salivary biomarkers of obstruc-
tive sleep apnea syndrome in children. Pediatr Pulmonol.
2014;49:1145--52.
10. Brownlee KK, Moore AW, Hackney AC. Relationship between
circulating cortisol and testosterone: inﬂuence of physical exer-
cise. JSSM. 2005;4:76--83.
11. Peeri M, Zamani M, Farzanegi P, Rakhshanizadeh A, Piri E. Effect
of sleep disorder on the levels of testosterone, cortisol and T/C
ratio in young football players. Ann Biol Res. 2012;3:3798--804.
12. Glenn LA, Raine A, Schug RA, Gao YD, Granger DA. Increased
testosterone to cortisol ratio in psychopathy. J Abnorm Psychol.
2011;120:389--99.
13. Terburg D, Morgan B, van Honk J. The testosterone-cortisol
ratio: a hormonal marker for proneness to social aggression.
Int J Law Psychiatry. 2009;32:216--23.
14. Smith GD, Ben-Shlomo Y, Beswick A, Yarnell J, Lightman S,
Elwood A. Cortisol, testosterone, and coronary heart disease:
prospective evidence from the Caerphilly Study. Circulation.
2005;112:332--40.
15. Fernández-Guasti A, Fiedler JL, Herrera L, Handa RJ. Sex,
stress, and mood disorders: at the intersection of adrenal and
gonadal hormones. Horm Metab Res. 2012;44:607--18.
16. Anderson ML, Tuﬁk S. The effects of testosterone on sleep and
sleep-disordered breathing in men: its bidirectional interaction
with erectile function. Sleep Med Rev. 2008;12:365--79.
17. Johns MW. A new method for measuring daytime sleepiness: the
Epworth Sleepiness Scale. Sleep. 1991;14:50--5.
3535
8. Hamilton M. A rating scale for depression. J Neurol Neurosurg
Psychiatry. 1960;23:56--62.
9. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra
A. The international index of erectile function (IIEF) a multidi-
mensional scale for assessment of erectile dysfunction. Urology.
1997;49:822--30.
0. Iber C, Anoni-Israel S, Chesson AL, Qua SF. The AASM manual
for the scoring of sleep and associated events. Westchester, IL:
American Academy of Sleep Medicine; 2007.
1. Hackney AC, Viru A. Research methodology: endocrinology mea-
surements in exercise science and sports medicine. J Athl Train.
2008;43:631--9.
2. Gröschl M, Khöler H, Topf HG, Rupprecht T, Rauh M. Evaluation
of saliva collection devices for the analysis of steroids, pep-
tides and therapeutic drugs. J Pharm Biomed Anal. 2008;47:
478--86.
3. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer
DH. Two formulas for computation of the area under the
curve represent measures of total hormone concentration
versus time-dependent change. Psychoneuroendocrinology.
2003;28:916--31.
4. Cooke RR, McIntosh JE, McIntosh RP. Circadian variation in
serum free and non-SHBG-bound testosterone in normal men:
measurements, and simulation using a mass action model. Clin
Endocrinol (Oxf). 1993;39:163--71.
5. Plymate SR, Tenover JS, Bremmer WJ. Circadian variation
in testosterone, sex hormone-binding globulin, and calcu-
lated non-sex hormone-binding globulin bound testosterone
in healthy young and elderly men. J Androl. 1989;10:
366--71.
6. Axelsson J, Ingre M, Åkerstedt T, Holmbäck U. Effects of acutely
displaced sleep on testosterone. J Clin Endocrinol Metab.
2005;90:4530--5.
7. Raff H, Ettema SL, Eastwood DC, Woodson BT. Salivary corti-
sol in obstructive sleep apnea: the effect of CPAP. Endocrine.
2011;40:137--9.
8. Ghiciuc CM, Dima-Cozma CL, Pasquali V, Renzi P, Simeoni S,
Lupusoru CE, et al. Awakening responses and diurnal ﬂuctua-
tions of salivary cortisol, DHEA-S and -amylase in healthy male
subjects. Neurondocrinol Lett. 2011;32:475--80.
9. Nater UM, Maloney E, Roumiana S, Gurbaxani BM, Lin JM,
Jones JF, et al. Attenuated morning salivary cortisol concen-
trations in a population-based study of persons with chronic
fatigue syndrome and well controls. J Clin Endocrinol Metab.
2008;93:703--9.
0. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB,
Coviello AD, et al. Age trends in the level of serum testosterone
and other hormones in middle-aged men: longitudinal results
from Massachusetts Male Aging Study. J Clin Endocrinol Metab.
2002;87:589--98.
1. de Wit LM, Fokkema M, van Straten A, Lamers F, Cuijpers P,
Penninx BW. Depressive and anxiety disorders and the associa-
tion with obesity, physical and social activities. Depress Anxiety.
2010;27:1057--65.
2. Petersen M, Kristensen E, Berg S, Midgren B. Sexual function
in male patients with obstructive sleep apnoea. Clin Respir J.
2010;4:186--91.
3. Bercea RM, Mihaescu T, Cojocaru C, Bjorvatn B. Fatigue and
serum testosterone in obstructive sleep apnea patients. Clin
Respir J. 2015;9:342--9.
4. Rilling JC, Worthman CM, Campbell BC, Stallings JF, Mbizva M.
Ratios of plasma and salivary testosterone throughout puberty:
production versus bioavailability. Steroids. 1996;61:374--8.
